Trials / Completed
CompletedNCT00645112
A Comparison of Safety and Efficacy of Cefdinir Oral Suspension Versus Azithromycin in Pediatric Subjects With Acute Otitis Media
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 357 (actual)
- Sponsor
- Abbott · Industry
- Sex
- All
- Age
- 6 Months – 6 Years
- Healthy volunteers
- Not accepted
Summary
To compare the safety and efficacy of cefdinir oral suspension, 7 mg/kg every 12 hours for 5 days, to azithromycin oral suspension 10 mg/kg/day (Day 1) then 5 mg/kg/day (Days 2-5) for a total of 5 days, in children between 6 months and 6 years of age, with AOM.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | cefdinir (Omnicef) | oral suspension, 7 mg/kg every 12 hours for 5 days |
| DRUG | azithromycin | oral suspension 10 mg/kg QD on Day 1 then 5 mg/kg QD on Days 2-5 for a total of 5 days. |
Timeline
- Start date
- 2003-11-01
- Primary completion
- 2004-01-01
- First posted
- 2008-03-27
- Last updated
- 2008-03-27
Locations
30 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00645112. Inclusion in this directory is not an endorsement.